Labetalol Hydrochloride

The hydrochloride form of labetalol, a third generation selective alpha-1-adrenergic antagonist and non-selective beta-adrenergic antagonist with vasodilatory and antihypertensive properties. Labetalol competitively binds to alpha-1-adrenergic receptors in vascular smooth muscle, thereby inhibiting the adrenergic stimulation of endothelial cell function and vasoconstriction in peripheral blood vessels. This agent also binds to beta-receptors in the bronchial and vascular smooth muscle, resulting in a decrease in adrenergic stimulation. The result is a decrease in resting and exercise heart rates, cardiac output, and in both systolic and diastolic blood pressure, thereby resulting in vasodilation, and negative chronotropic and inotropic cardiac effects. (NCI Thesaurus)

YOU MAY ALSO LIKE

Labetalol

A third generation selective alpha-1-adrenergic antagonist and non-selective beta-adrenergic antagonist with vasodilatory and antihypertensive properties. Labetalol competitively binds to alpha-1-adrenergic receptors in…

Labeling, Not Otherwise Specified

Any labeling operation not elsewhere described.

Labeling Supplement

For NDAs, ANDAs, and BLAs, this represents a request to modify an existing label that do not rise to the level of…

Labeling Activity

The action of affixing an identifier to an item or the container for an item.

Labeling

All written, printed, or graphic matter accompanying an article at any time while such article is in interstate commerce or held for…

Labeler Regulatory Contact for FDA

The representative of a labeler company who is the authorized channel for communication between the company and the FDA.